These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6107337)

  • 21. Displacement from protein binding of sulphormethoxine by phenylbutazone using in vivo dialysis in rats.
    McQueen EG
    Br J Pharmacol; 1969 May; 36(1):29-34. PubMed ID: 5768126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of binding on drug metabolism and distribution.
    Dayton PG; Israili ZH; Perel JM
    Ann N Y Acad Sci; 1973 Nov; 226():172-94. PubMed ID: 4588440
    [No Abstract]   [Full Text] [Related]  

  • 24. Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis.
    Yokel RA; Allen DD; Burgio DE; McNamara PJ
    J Pharmacol Toxicol Methods; 1992 May; 27(3):135-42. PubMed ID: 1498341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hydroxylation of phenylbutazone and imipramine by rabbit liver microsomes].
    LEYBOLD K; STAUDINGER H
    Z Gesamte Exp Med; 1962; 136():78-85. PubMed ID: 14464938
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain uptake of metabolites and drugs following carotid arterial injections.
    Oldendorf WH
    Trans Am Neurol Assoc; 1971; 96():46-50. PubMed ID: 4400654
    [No Abstract]   [Full Text] [Related]  

  • 27. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 28. Antipyrine concentrations in liver and blood monitored by microdialysis of unrestrained conscious rats.
    Kurata N; Inagaki M; Kobayashi S; Nishimura Y; Oguchi K; Yasuhara H
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):363-9. PubMed ID: 8480081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of lipophilic model compounds into the isolated perfused rat epididymal adipose tissue.
    Gubser R; Di Francesco C; Bickel MH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):967-71. PubMed ID: 3086542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.
    Ishizaki J; Yokogawa K; Ichimura F; Ohkuma S
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1088-98. PubMed ID: 10945864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interindividual differences in pharmacokinetics in man: clinical importance.
    Sjöqvist F
    Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 34. Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding.
    Raisman R; Briley MS; Langer SZ
    Eur J Pharmacol; 1980 Feb; 61(4):373-80. PubMed ID: 7371714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats.
    von Bahr C; Alexanderson B; Azarnoff DL; Sjoqvist F; Orrenius S
    Eur J Pharmacol; 1970 Jan; 9(1):99-105. PubMed ID: 5434299
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics of drugs in the elderly].
    Petrin A
    Int J Clin Pharmacol; 1974 Mar; 9(2):157-9. PubMed ID: 4133294
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of in vitro preparations for semi-quantitative prediction of in vivo drug metabolism.
    De Graaf IA; Van Meijeren CE; Pektaş F; Koster HJ
    Drug Metab Dispos; 2002 Oct; 30(10):1129-36. PubMed ID: 12228190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
    Pacifici GM; Viani A
    Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equilibrium dialysis for determination of protein binding or imipramine--evaluation of a method.
    Kristensen CB; Gram LF
    Acta Pharmacol Toxicol (Copenh); 1982 Feb; 50(2):130-6. PubMed ID: 7072503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.